Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Genomics Immunology and Healthcare ETF (IDNA)

Genomics Immunology and Healthcare ETF (IDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 168,284,300
  • Shares Outstanding, K 6,150
  • 60-Month Beta 0.86
Trade IDNA with:
  • Price/Earnings ttm 11.83
  • Annual Dividend & Yield 0.14 (0.49%)
  • Most Recent Dividend 0.136 on 06/09/22
  • Management Fee 0.47%
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 26.61% ( +14.34%)
  • Historical Volatility 26.83%
  • IV Percentile 69%
  • IV Rank 24.49%
  • IV High 107.15% on 01/10/23
  • IV Low 0.49% on 08/19/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 91
  • Open Int (30-Day) 88

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.24 +7.19%
on 01/10/23
28.06 -3.58%
on 02/02/23
+1.40 (+5.44%)
since 01/06/23
3-Month
24.20 +11.80%
on 12/28/22
29.29 -7.63%
on 11/15/22
+0.01 (+0.06%)
since 11/04/22
52-Week
24.20 +11.80%
on 12/28/22
36.88 -26.65%
on 02/10/22
-8.40 (-23.70%)
since 02/04/22

Most Recent Stories

More News
Will 2023 be the Year of Cathie Wood ETFs?

Cathie Wood, famous for the success of Ark Investment's winning products, had faced a miserable fate in 2022. Will her ETFs see success in 2023?

DRIV : 24.17 (-1.47%)
ARKK : 42.24 (-1.42%)
IPAY : 44.47 (-2.11%)
BATT : 13.75 (-1.79%)
GNOM : 13.63 (-1.80%)
IDNA : 26.97 (-1.35%)
Moderna ETFs Rallying on COVID-19 Vaccine Booster Shot Update

Moderna has been rallying on the latest positive booster shot-related update.

MRNA : 170.27 (-1.72%)
IBB : 135.61 (-0.72%)
BBH : 167.11 (-0.12%)
IDNA : 26.97 (-1.35%)
GERM : 24.33 (-0.31%)
Is ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie Wood

Though Cathie Wood's Ark Investment's star products underperformed in 2021 and may continue to lag the broader market in 2022, Wood's fans may follow these ETF strategies to capitalize on her vision.

TSLA : 194.76 (+2.52%)
TWTR : 53.70 (+0.66%)
SOCL : 37.44 (-1.14%)
ARKW : 52.64 (-1.96%)
ARKQ : 50.49 (-1.00%)
ARKK : 42.24 (-1.42%)
IPAY : 44.47 (-2.11%)
ARKG : 34.56 (-2.04%)
KARS : 33.05 (-1.46%)
BATT : 13.75 (-1.79%)
ARKF : 19.39 (-1.72%)
GNOM : 13.63 (-1.80%)
Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron

Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.

MRNA : 170.27 (-1.72%)
IBB : 135.61 (-0.72%)
BBH : 167.11 (-0.12%)
IDNA : 26.97 (-1.35%)
GERM : 24.33 (-0.31%)
Moderna ETFs to Rally on Positive COVID-19 Booster Shot News

Moderna is expected to gain approval for booster shots for its COVID-19 vaccine.

MRNA : 170.27 (-1.72%)
IBB : 135.61 (-0.72%)
BBH : 167.11 (-0.12%)
IDNA : 26.97 (-1.35%)
GERM : 24.33 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 28.17
2nd Resistance Point 27.93
1st Resistance Point 27.64
Last Price 26.97
1st Support Level 27.11
2nd Support Level 26.87
3rd Support Level 26.58

See More

52-Week High 36.88
Fibonacci 61.8% 32.04
Fibonacci 50% 30.54
Fibonacci 38.2% 29.04
Last Price 26.97
52-Week Low 24.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar